Investigation Overview
August 8, 2014 (Shareholders Foundation) - An investigation on behalf of investors of Regeneron Pharmaceuticals Inc (NASDAQ:REGN shares over potential securities laws violations by Regeneron Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchas...
You must register (for free) or login to view the entire investigation.